Skip to main content
SpringerLink
Log in

Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings

  • Nuclear Cardiology Bullet
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

References

  1. Konety SH, Wooldridge JE, Kerber RE. Primary cardiac non-Hodgkin’s lymphoma diagnosed by transthoracic echocardiography. Echocardiography 2006;23:147-8.

    Article  PubMed  Google Scholar 

  2. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: Diagnosis and management. Lancet Oncol 2005;6:219-28.

    Article  PubMed  Google Scholar 

  3. Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: An analysis of presentation, treatment, and outcome patterns. Cancer 2011;117:581-9.

    Article  PubMed  Google Scholar 

  4. Miguel CE, Bestetti RB. Primary cardiac lymphoma. Int J Cardiol 2010 (online first).

  5. Devbhandari MP, Meraj S, Jones MT, Kadir I, Bridgewater B. Primary cardiac sarcoma: Reports of two cases and a review of current literature. J Cardiothorac Surg 2007;2:34.

    Article  PubMed  Google Scholar 

  6. Moore JA, DeRan BP, Minor R, Arthur J, Fraker TD Jr. Transesophageal echocardiographic evaluation of intracardiac lymphoma. Am Heart J 1992;124:514-6.

    Article  PubMed  CAS  Google Scholar 

  7. Mügge A, Daniel WG, Haverich A, Lichtlen PR. Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches. Circulation 1991;83:70-8.

    PubMed  Google Scholar 

  8. Araoz PA, Eklund HE, Welch TJ, Breen JF. CT and MR imaging of primary cardiac malignancies. Radiographics 1999;19:1421-34.

    PubMed  CAS  Google Scholar 

  9. Ryu SJ, Choi BW, Choe KO. CT and MR findings of primary cardiac lymphoma: Report upon 2 cases and review. Yonsei Med J 2001;42:451-6.

    PubMed  CAS  Google Scholar 

  10. Zhang M, Li B, Jiang X. PET/CT imaging in a case of cardiac liposarcoma. J Nucl Cardiol 2008;15:473-5.

    Article  PubMed  Google Scholar 

  11. Kosuda S, Kusano S, Ohsuzu F. Primary myocardial lymphoma demonstrated by Tl-201, Tc-99m sestamibi, and Ga-67 SPECT. Clin Nucl Med 1998;23:482-3.

    Article  PubMed  CAS  Google Scholar 

  12. Su HY, Huang HL, Sun CM, Hou SM, Chen ML. Primary cardiac lymphoma evaluated with integration of PET/CT and contrast-enhanced CT. Clin Nucl Med 2009;34:298-301.

    Article  PubMed  Google Scholar 

  13. Cho JM, Sohn IS, Yang YJ. Heart in the heart: Dual faced primary cardiac lymphoma on PET-CT. Int J Cardiol 2010;142:e40-1.

    Article  PubMed  Google Scholar 

  14. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579-86.

    Article  PubMed  Google Scholar 

  15. Tsukamoto N, Kojima M, Hasegawa M, Oriuchi N, Matsushima T, Yokohama A, et al. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: Relation to histologic subtypes based on the World Health Organization classification. Cancer 2007;110:652-9.

    Article  PubMed  Google Scholar 

  16. Hicks RJ, Mac Manus MP, Seymour JF. Initial staging of lymphoma with positron emission tomography and computed tomography. Semin Nucl Med 2005;35:165-75.

    Article  PubMed  Google Scholar 

  17. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538-43.

    Article  PubMed  Google Scholar 

  18. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teräs M, Haaparanta M, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 1992;89:1767-74.

    Article  PubMed  CAS  Google Scholar 

  19. Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Morris DL, Craig JC. Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest 1985;76:1819-27.

    Article  PubMed  CAS  Google Scholar 

  20. Watanabe R, Tomita N, Takeuchi K, Sakata S, Tateishi U, Tanaka M, et al. SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leuk Lymphoma 2010;51:279-83.

    Article  PubMed  Google Scholar 

  21. Mikhaeel NG. Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas. Eur J Nucl Med Mol Imaging 2006;33:22-6.

    Article  PubMed  Google Scholar 

Download references

Conflicts of Interest

The authors have indicated they have no functional conflicts of interest.

Author information

Authors and Affiliations

  1. Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjyuku-ku, Tokyo, 162-8655, Japan

    Ryogo Minamimoto MD, PhD, Miyako Morooka MD, Kazuo Kubota MD, PhD & Takuya Mitsumoto BS

  2. Department of Radiology, National Center of Neurology and Psychiatry, Tokyo, Japan

    Kimiteru Ito MD

  3. Medicheck Imaging Center, Iwai Medical Foundation, Tokyo, Japan

    Yoko Masuda-Miyata MD, PhD

  4. Division of Hematology, Internal Medicine, National Center for Global Health and Medicine, Tokyo, Japan

    Risen Hirai MD

  5. Division of Cardiology, Internal Medicine, National Center for Global Health and Medicine, Tokyo, Japan

    Osamu Okazaki MD, PhD & Michiaki Hiroe MD, PhD, FJCC

Authors
  1. Ryogo Minamimoto MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miyako Morooka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuo Kubota MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kimiteru Ito MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoko Masuda-Miyata MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takuya Mitsumoto BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Risen Hirai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Osamu Okazaki MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michiaki Hiroe MD, PhD, FJCC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryogo Minamimoto MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minamimoto, R., Morooka, M., Kubota, K. et al. Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings. J. Nucl. Cardiol. 18, 516–520 (2011). https://doi.org/10.1007/s12350-011-9358-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-011-9358-z

Keywords

Search

Navigation